target directory

the study targets the combined therapeutic effects of n acetylcysteine nac and eh 301 which includes nicotinamide riboside and pterostilbene in conjunction with riluzole clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.